Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Clinical trial NCT02760498 · COMPLETED
Trial details
- NCT number
- NCT02760498
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-07
- Primary completion
- 2023-10-18
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.